AbCellera Biologics Inc.
NASDAQ:ABCL
2.4 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2001 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -162.857 | -146.398 | 158.519 | 153.464 | 118.918 | -2.211 | 0.309 | 0 |
| Depreciation & Amortization
| 90.849 | 30.894 | 33.102 | 17.25 | 5.271 | 1.847 | 0.918 | 0 |
| Deferred Income Tax
| 0 | 1.96 | -2.114 | -2.018 | 2.098 | 0 | 0 | 0 |
| Stock Based Compensation
| 67.581 | 64.183 | 49.481 | 30.646 | 8.397 | 0.89 | 0.615 | 0 |
| Change In Working Capital
| 0 | 13.225 | 29.825 | 41.672 | -116.701 | 1.973 | 1.911 | 0 |
| Accounts Receivables
| 0 | -45.933 | -22.715 | -37.386 | -5.467 | -1.803 | -0.477 | 0 |
| Inventory
| 0 | 18.253 | 0 | 40.919 | -134.348 | -0.15 | -0.898 | 0 |
| Accounts Payables
| 0 | -15.104 | 1.066 | 1.4 | 6.601 | 0.15 | 0.18 | 0 |
| Other Working Capital
| 0 | 56.009 | 51.474 | 36.739 | 16.513 | 3.776 | 3.106 | 0 |
| Other Non Cash Items
| -104.129 | -7.741 | 8.547 | 3.57 | 4.707 | 0.194 | -0.188 | 0 |
| Operating Cash Flow
| -108.556 | -43.877 | 277.36 | 244.584 | 22.69 | 2.694 | 3.565 | 0 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -78.396 | -77.507 | -72.66 | -58.452 | -14.673 | -3.997 | -5.307 | 0 |
| Acquisitions Net
| 0 | -13.69 | -25.679 | -41.78 | -106.89 | 0 | 0 | 0 |
| Purchases Of Investments
| -765.086 | -1,066.159 | -781.351 | -292.244 | -19.247 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 910.937 | 510.631 | 27.608 | 19.247 | 0 | 0 | 0 |
| Other Investing Activites
| 964.891 | 25.311 | 16.434 | 32.621 | 1.783 | -1.783 | 0 | 0 |
| Investing Cash Flow
| 121.409 | -221.108 | -352.625 | -332.247 | -119.78 | -5.78 | -5.307 | 0 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 11.59 | 2.755 | 5.487 | 85.151 | 0.181 | 1.98 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 4.615 | 522.84 | 0.014 | 2.612 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -0.011 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 12.769 | -1.234 | -4.383 | -9.373 | 673.164 | -0.011 | 7.594 | 0 |
| Financing Cash Flow
| 12.769 | 10.356 | -1.628 | -3.886 | 683.653 | 0.195 | 12.186 | 0 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -2.617 | 0.589 | -9.599 | -1.425 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 23.005 | -254.04 | -86.492 | -92.974 | 586.563 | -2.891 | 10.444 | 0 |
| Cash At End Of Period
| 183.615 | 160.61 | 414.65 | 501.142 | 594.116 | 7.553 | 10.444 | 0 |